The US healthcare reform plan has pushed biotechnology shares up sharply. Volatility in the...

The main Q4 topics for equities include the US presidential election, a potential rate hike in...

Saxo Bank’s Head of Equity Strategy Peter Garnry is looking to buy shares in Gilead Sciences...

More than 230 companies will be reporting their quarterly earnings this week. Saxo Bank's Peter...

It’s been a rough start to the year for many assets including equities, which have seen a...

With so many central banks meeting this week, Saxo's Kay Van-Petersen discusses the currency...

Biotechnology stocks have fallen significantly since their July peak. But because of the noise...

The massive rally in the biotechnology sector is not over according to Serge Berger, also known...

Expect them to be disappointing. That's what Saxo's Peter Garnry predicts ahead of...

Serge Berger, who is also known as The Steady Trader, believes the NASDAQ Biotechnology ETF...

The NASDAQ can go even higher says Saxo's Peter Garnry. On Monday the index reached 5,000 for the...

It's the largest US stock exchange in terms of volume and market share and the Nasdaq is...